A Message from the ESMO President By Ogkologos - March 17, 2020 35 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell Anal Cancer Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab Alone in Patients with ES-SCLC FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-mutated Non-Small Cell Lung Cancer MOST POPULAR Patients with Early Stage NSCLC Have a Higher TMB in Comparison... October 9, 2020 This Breast Cancer Patient Is Using Boudoir Photography to Reclaim Her... November 5, 2019 After Struggling With Chronic Illnesses Most of Her Life, This Author... June 21, 2021 Insights Into the Biology of Response and Resistance to MAPK Pathway... October 16, 2024 Load more HOT NEWS Marshall University Study Finds That Walnuts Suppress Breast Cancer Growth And... Datopotamab Deruxtecan Shows Promising Activity in Heavily Pretreated Advanced HR-positive/HER2-negative and... 2020 round-up: Our biggest cancer stories of the year Tumors With KRAS G12C Mutation Respond to Adagrasib and Using Toripalimab...
